Login / Signup

Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis.

Thomas KarlasDavid PetroffJürgen FeisthammelSebastian BeerMatthias BlüherTatjana SchützRalf LichtinghagenAlbrecht HoffmeisterJohannes Wiegand
Published in: Obesity surgery (2022)
One year of DJBL therapy is associated with relevant improvements in non-invasive markers of steatosis and NASH, but not fibrosis, and is accompanied by a substantial number of complications. Given the lack of alternatives, DJBL deserves further attention.
Keyphrases
  • weight loss
  • working memory
  • insulin resistance
  • ultrasound guided
  • high fat diet
  • liver injury
  • roux en y gastric bypass
  • stem cells
  • metabolic syndrome
  • bariatric surgery
  • combination therapy
  • drug induced